Drug Discovery

Advances in computer simulations allow researchers to look at G protein-coupled receptors in more detail than ever before.

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society.

Biotech Versus the Superbugs: Interviewing Centauri Therapeutics CSO Helen Bright

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

How fluid flow through the body can affect the ways in which antibiotics work.

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Experts explain why these are two important areas to watch in the near future of pharma R&D.

Purdue University’s Young Institute is tackling pharma’s toughest challenges— from mRNA stability to aseptic manufacturing.